Effects of antioxidants on vascular health

British Medical Bulletin

Volumn 55, Issue 3, 1999, Pages 568-577

  Duthie, Garry G ^a   Bellizzi, Mary C ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FLAVONOID; FREE RADICAL; LOW DENSITY LIPOPROTEIN;

ARTERY INTIMA; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; HIGH RISK POPULATION; HUMAN; MACROPHAGE; OXIDATION; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

EID: 0032738503     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902637     Document Type: Review

References (42)

1. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol 1997; 26: 1-13
2. Slater TF. Free-radical mechanisms in tissue injury. Biochem J 1984; 222: 1-15
3. Diplock AT. Antioxidants and disease prevention. Mol Aspects Med 1994; 15: 293-376
4. Krinsky NI Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992; 200: 248-54
5. Scott G. Antioxidants in Science, Technology, Medicine and nutrition. Chichester: Albion, 1997
6. Steinberg D. Low density lipoprotein and its pathological significance. J Biol Chem 1997; 272: 20963-6
7. Westhuyzen J. The oxidation hypothesis of atherosclerosis: an update. Ann Clin Lab Sci 1997; 27: 1-10
8. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. New Engl J Med 1997; 337: 408-16
9. Pratico D, Iuliano L, Mauriello A et al. Localisation of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997; 100: 2028-34
10. Yla-Herttuala S, Palinski W, Rosenfield ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086-95
11. Holvoet P, Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998; 137: S33-8
12. Holvoet P, Perez G, Zhao Z et al. Malonaldehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest 1995; 95: 2611-9
13. Aviram M, Fuhram B. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 1998; 137: S45-50
14. Cynshi O, Kawabe Y, Suzuki T et al. Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc Natl Acad Sci USA 1998; 95: 10123-8
15. Williams RJ, Motteram JM, Sharp CH et al. Dietary vitamin E and the attenuation of early lesion development in modified Wattanabe rabbits. Atherosclerosis 1992; 94: 153-9
16. Heller FR, Descamps O, Hondekjikn J-C. LDL oxidation: therapeutic perspectives. Atherosclerosis 1998; 137: 25-31
17. Stephens NG, Parsons A, Schofield PM et al. Randomised control trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-6
18. Rapola J, Virtamo J, Ripatti S et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-20
19. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5
20. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9
21. Stampler MJ, Hennekens MD, Marson JE et al. Vitamin E consumption and risk of coronary heart disease in women. N Engl J Med 1993; 328: 1444-9.
22. Rimm EB, Stampler MJ, Ascherio A et al. Vitamin E consumption and risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6
23. Kushi LH, Folsom AR, Prineas RJ et al. Dietary antioxidant vitamins and death from coronary heart disease. N Engl J Med 1996; 334: 1156-62
24. Bellizzi MC, Franklin MF, Duthie GG, James WPT. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr 1994; 48: 822-31
25. Hertog MGL, Kromhout D, Aravanis C et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995; 155: 381-6
26. Riemersma RA, Oliver M, Elton RA et al. Plasma antioxidants and coronary heart disease: vitamins C and E and selenium. Eur J Clin Nutr 1990; 44: 292-5
27. Gey KF. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 1987: 37; 53-91
28. Hertog MGL, Feskens EJ, Hollman PC et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly. Lancet 1993; 342: 833-7
29. Knekt P, Reunanen A, Jarvinen R et al. Antioxidant vitamin intake and coronary mortality in a longitudinal study. Am J Epidemiol 1994; 139: 1180-90
30. Hertog MGL, Sweetman PM, Fehily AM et al. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly study. Am J Clin Nutr 1997; 65: 1489-94
31. Knekt P, Reunanen A, Jarvinen R et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180-90
32. Losonscy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and the risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996; 64: 190-6
33. Evans RW, Shaten BJ, Day BW et al. Prospective association between lipid soluble antioxidants and coronary heart disease in men - The Multiple Risk Factor Intervention Trial. Am J Epidemiol 1998; 147: 180-6
34. Hense HW, Stender M, Bors W et al. Lack of association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993; 103: 21-8
35. Salonen JT, Salonen R, Pentilla I et al. Serum fatty acids, apoprotems, selenium and vitamin antioxidants and risk of death from coronary artery disease. Am J Cardiol 1985; 56: 226-31
36. Duthie GG, Beattie JAG, Arthur JR et al. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris. Nutrition 1994; 10: 313-6
37. Kardinaal AFM, Kik FJ, Ringstaad J et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993; 342: 1379-84
38. Sklodowska M, Wasowicz W, Gromadzinska J et al. Selenium and vitamin E concentrations in plasma and erythrocytes of angina pectoris patients. Trace Elem Med 1991; 8: 113-7
39. Riemersma RA, Wood DA, Macintyre CCA et al. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337: 1-5
40. Brown KM, Morrice PC, Duthie GG. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and non-smokers: dose response of vitamin E supplementation. Am J Clin Nutr 1997; 65: 496-502
41. Meyer F, Bairati I, Dagenais GR. Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can J Cardiol 1996; 12:930-4
42. Daviglus ML, Orencia AJ, Dyer AR et al. Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric study. Neuroepidemiology 1997; 16: 69-77